Cited by 2,155Heart Failure Treatment and ManagementBlood Pressure and Hypertension StudiesCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

The Progression From Hypertension to Congestive Heart Failure

Levy, Daniel·1996·JAMA: The Journal of the American Medical Association

DOI 10.1001/jama.1996.03530440037034

Open this paper in CoChat — free account

Abstract

OBJECTIVES: - To study the relative and population-attributable risks of hypertension for the development of congestive heart failure (CHF), to assess the time course of progression from hypertension to CHF, and to identify risk factors that contribute to the development of overt heart failure in hypertensive subjects. DESIGN: - Inception cohort study. SETTING: - General community. PARTICIPANTS: - Original Framingham Heart Study and Framingham Offspring Study participants aged 40 to 89 years and free of CHF. To reflect more contemporary experience, the starting point of this study was January 1, 1970. EXPOSURE MEASURES: - Hypertension (blood pressure of at least 140 mm Hg systolic or 90 mm Hg diastolic or current use of medications for treatment of high blood pressure) and other potential CHF risk factors were assessed at periodic clinic examinations. OUTCOME MEASURE: - The development of CHF. RESULTS: - A total of 5143 eligible subjects contributed 72422 person-years of observation. During up to 20.1 years of follow-up (mean, 14.1 years), there were 392 new cases of heart failure; in 91% (357/392), hypertension antedated the development of heart failure. Adjusting for age and heart failure risk factors in proportional hazards regression models, the hazard for developing heart failure in hypertensive compared with normotensive subjects was about 2-fold in men and 3-fold in women. Multivariable analyses revealed that hypertension had a high population-attributable risk for CHF, accounting for 39% of cases in men and 59% in women. Among hypertensive subjects, myocardial infarction, diabetes, left ventricular hypertrophy, and valvular heart disease were predictive of increased risk for CHF in both sexes. Survival following the onset of hypertensive CHF was bleak; only 24% of men and 31% of women survived 5 years. CONCLUSIONS: - Hypertension was the most common risk factor for CHF, and it contributed a large proportion of heart failure cases in this population-based sample. Preventive strategies directed toward earlier and more aggressive blood pressure control are likely to offer the greatest promise for reducing the incidence of CHF and its associated mortality.

Integrity signals

Registry

Crossref · 10.1001/jama.1996.03530440037034

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,804
Analysis of Survival Data
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,269
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
Swedberg, K. B., & KJEKSHUS, J. K. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
The epidemiology of heart failure: The Framingham Study
Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,246
Self-citation

Show all 46 references

Sorted by citations

Items 601–700 of 999

Current Technique of Fluid Status Assessment
Peacock, W. F., & Soto, K. M. (2010) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2010.00166.x · Cited by 41
Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease — do we need to screen our patients?
Roberts, A. W., Clark, A. L., & Witte, K. K. (2009) · Diabetes and Vascular Disease Research · doi:10.1177/1479164109338774 · Cited by 43
“Hypertension increases the risk of heart failure twofold in men and threefold in women over that seen in normotensive subjects.(110) Hypertension in men is more likely than in women to cause systolic heart failure.”
Background
Heart Failure due to Ischaemic Heart Disease: Epidemiology, Pathophysiology and Progression
Cleland, J. G. F., & McGowan, J. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199906003-00003 · Cited by 42
Relationship Between High-Sensitivity Cardiac Troponin I and Blood Pressure Among Young and Healthy Adults
Aeschbacher, S., Schoen, T., Bossard, M., van der Lely, S., Glättli, K., Todd, J., Estis, J., Risch, M., Mueller, C. E., Risch, L., et al. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu226 · Cited by 41
Efficacy and Safety of Treating Stage 2 Systolic Hypertension With Olmesartan and Olmesartan/HCTZ: Results of an Open‐Label Titration Study
Izzo, J. L., Neutel, J. M., Silfani, T. N., Dubiel, R., Walker, F., & on behalf of the Study Investigators (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175x.2007.5713.x · Cited by 41
Ventricular Adrenomedullin System in the Transition From LVH to Heart Failure in Rats
Nishikimi, T., Tadokoro, K., Mori, Y., Wang, X., Akimoto, K., Yoshihara, F., Minamino, N., Kangawa, K., & Matsuoka, H. (2003) · Hypertension · doi:10.1161/01.hyp.0000053447.64213.c4 · Cited by 41
“23 Recent studies showed that (1) 2 molecular forms of plasma AM circulate in human plasma, (2) the major circulating form of AM is AM-Gly, and (3) both plasma AM-m and AM-Gly levels are increased in parallel in patients with hypertension and HF.”
Background
High Blood Pressure 2016: Why Prevention and Control Are Urgent and Important. The World Hypertension League, International Society of Hypertension, World Stroke Organization, International Diabetes Foundation, International Council of Cardiovascular Prevention and Rehabilitation, International Society of Nephrology
Campbell, N. R., Khalsa, T., Executive:, W. H. L., Lackland, D. T., Niebylski, M. L., Nilsson, P. M., Redburn, K. A., Orias, M., Zhang, X., International Society of Hypertension Executive:, et al. (2016) · The Journal of Clinical Hypertension · doi:10.1111/jch.12840 · Cited by 40
Impact of diabetes and hypertension on the heart
Pieske, B. M., & Wachter, R. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283031ab3 · Cited by 40
A review of the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Schwartz, G. L., & Sheps, S. G. (1999) · Current Opinion in Cardiology · doi:10.1097/00001573-199903000-00014 · Cited by 40
Heart Failure in Women
Taylor, A. L. (2015) · Current Heart Failure Reports · doi:10.1007/s11897-015-0252-x · Cited by 41
Inhibition of Hypertrophy, Per Se, May Not Be a Good Therapeutic Strategy in Ventricular Pressure Overload: Other Approaches Could Be More Beneficial
Crozatier, B., & Ventura‐Clapier, R. (2015) · Circulation · doi:10.1161/circulationaha.114.013895 · Cited by 40
“hypertension and diabetes mellitus in women and more coronary artery disease in men).(50) Although there are con-”
Background
Associations of Heart Failure with Sleep Quality: The Rotterdam Study
Zuurbier, L. A., Luik, A. I., Leening, M. J. G., Albert Hofman, D., Freak‐Poli, R., Franco, O. H., Stricker, B. H. C., & Tiemeier, H. W. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4454 · Cited by 40
“26,27 Furthermore, sleep-disordered breathing is highly prevalent in people with HF. 28 We adjusted for possible sleep apnea to take this into account.”
Hypothalamic Signaling in Body Fluid Homeostasis and Hypertension
Kinsman, B. J., Nation, H. N., & Stocker, S. D. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0749-7 · Cited by 40
European and US guidelines for arterial hypertension: similarities and differences
Angeli, F., Reboldi, G., Trapasso, M., Gentile, G., Pinzagli, M. G., Aita, A., & Verdecchia, P. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.01.016 · Cited by 42
Sleep Disturbances Independently Predict Heart Failure in Overweight Middle-Aged Men
Ingelsson, E., Lind, L., Ärnlöv, J., & Sundström, J. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.05.012 · Cited by 40
“Although coronary heart disease is a major risk factor for HF, the majority of HF cases are not preceded by a coronary event [6].”
BackgroundMethod
Diastolic Dysfunction in Arterial Hypertension
SIMONE, G. D., & Palmieri, V. (2001) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2001.00827.x · Cited by 40
Heart Failure in Women: Epidemiology, Biology and Treatment
Shah, R. U., Klein, L., & Lloyd‐Jones, D. M. (2009) · Women s Health · doi:10.2217/whe.09.50 · Cited by 42
Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients.
Haugen, E., Gan, L., Isic, A., Skommevik, T., & Fu, M. L. X. (2008) · PubMed Central · Cited by 40
Association of body mass, gender and race with heart failure primarily due to hypertension
Dunlap, S. H., Sueta, C. A., Tomasko, L., & Adams, K. F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00374-5 · Cited by 40
“Natural history studies continue to demonstrate that systemic hypertension is a significant risk factor for the development of heart failure (1).”
Background
Age-differential association between serum uric acid and incident hypertension
Lee, S. W., Kim, H. C., Nam, C. M., Lee, H., Ahn, S. V., Oh, Y. A., & Suh, I. (2018) · Hypertension Research · doi:10.1038/s41440-018-0168-4 · Cited by 39
High Blood Pressure in Sub‐Saharan Africa: Why Prevention, Detection, and Control are Urgent and Important
Campbell, N. R. C., Bovet, P., Schutte, A. E., Lemogoum, D., & Nkwescheu, A. S. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12599 · Cited by 39
The Progression From Hypertension to Heart Failure
DEEDWANIA, P. C. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00335-x · Cited by 38
Recent advances in cardiac hypertrophy
Olivetti, G. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00298-9 · Cited by 39
Current perspectives on combination therapy in the management of hypertension
Mallat, S. G., Tanios, B. Y., & Itani, H. S. (2013) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s33985 · Cited by 38
Determinants of Salt-Restriction-Spoon Using Behavior in China: Application of the Health Belief Model
Chen, J., Liao, Y., Li, Z., Tian, Y., Yang, S., He, C. G., Tu, D.-H., & Sun, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083262 · Cited by 39
“According to the results of many other studies, hypertension is a major risk factor for stroke [2], renal disease [3] and heart failure [4].”
Result
Race and Sex Differences in Modifiable Risk Factors and Incident Heart Failure
Kubicki, D. M., Xu, M., Akwo, E. A., Dixon, D., Muñoz, D., Blot, W. J., Wang, T. J., Lipworth, L. P., & Gupta, D. K. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.11.001 · Cited by 38
“Most studies of HF risk factors have been conducted in predominantly middle-income, white cohorts from populations with relatively low rates of HF, such as the Framingham Heart Study (FHS), Olmsted County, MN, and the Atherosclerosis Risk in Communities (ARIC) study.(7)(8)(9) The relative contributions of modifiable r…”
Background
Blood Pressure Increases in OSA due to Maintained Neurovascular Sympathetic Transduction: Impact of CPAP
Tamisier, R., Tan, C. O., Pépin, J., Levy, P. A., & Taylor, J. A. (2015) · SLEEP · doi:10.5665/sleep.5252 · Cited by 42
Risk of Heart Failure in Patients With Recent-Onset Type 2 Diabetes: Population-Based Cohort Study
Leung, A. A. C., Eurich, D. T., Lamb, D. A., Majumdar, S. R., Johnson, J. A., Blackburn, D. F., & McAlister, F. A. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.10.004 · Cited by 38
Urinary Kidney Injury Molecule 1 and Incidence of Heart Failure in Elderly men
Carlsson, A. C., Larsson, A. O., Helmersson‐Karlqvist, J., Lind, L., Ingelsson, E., Larsson, T. E., Sundström, J., & Ärnlöv, J. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs187 · Cited by 37
“Electrographic LV hypertrophy (ECG-LVH) was defined as high amplitude R-waves according to the revised Minnesota code, together with an LV strain pattern.(13) Prevalent cardiovascular disease at baseline was defined as a history of ischaemic heart disease or cerebrovascular disease, or Q-, QS-complexes, or LBBB in bas…”
Method
Circulating levels of persistent organic pollutants (POPs) are associated with left ventricular systolic and diastolic dysfunction in the elderly
Lind, Y. S., Lind, P., Salihović, S., van Bavel, B., & Lind, L. (2013) · Environmental Research · doi:10.1016/j.envres.2013.02.007 · Cited by 37
Speckle tracking analysis
Cameli, M., Ciccone, M. M., Maiello, M. R., Modesti, P. A., Muiesan, M. L., Scicchitano, P., Novo, S., Palmiero, P., Saba, P. S., & Pedrinelli, R. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000073 · Cited by 37
Addressing Comorbidities in Heart Failure
Bavishi, A. A., & Patel, R. B. (2020) · Heart Failure Clinics · doi:10.1016/j.hfc.2020.06.005 · Cited by 40
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology
Piepoli, M. F., Adamo, M., Barison, A., Bestetti, R. B., Biegus, J., Böhm, M., Butler, J., Carapetis, J. R., Ceconi, C., Chioncel, O. D., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab147 · Cited by 43
Enhancing hypertension awareness and management in the elderly: Lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP)
Jones, C., Simpson, S. H., Mitchell, D., Haggarty, S., Campbell, N. R. C., Then, K. L., Lewanczuk, R. Z., Sebaldt, R. J., Farrell, B. J., Dolovich, L. R., et al. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70634-2 · Cited by 37
“Accepted October 7, 2007 Elevated blood pressure, or hypertension, is a well established and modifiable risk factor for cardiovascular diseases, including stroke, ischemic heart disease and heart failure (1-9).”
Background
Long Pentraxin PTX3 Exacerbates Pressure Overload–Induced Left Ventricular Dysfunction
Suzuki, S., Shishido, T., Funayama, A., Netsu, S., Ishino, M., Kitahara, T., Sasaki, T., Katoh, S., Otaki, Y., Watanabe, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053133 · Cited by 37
“Left ventricular hypertrophy (LVH) is an adaptive response of the heart to pressure or volume overload and is recognized as an independent risk factor for cardiovascular disease, congestive heart failure (CHF), and cardiac sudden death [1].”
Background
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2005) · Cited by 37
The Association of Hospital Volume With Mortality and Costs of Care for Stroke in Japan
Tsugawa, Y., Kumamaru, H., Yasunaga, H., Hashimoto, H., Horiguchi, H., & Ayanian, J. Z. (2013) · Medical Care · doi:10.1097/mlr.0b013e31829c8b70 · Cited by 37
Association of heart disease with diabetes and hypertension in patients with ESRD
Xue, J. L., Frazier, E. T., Herzog, C. A., & Collins, A. J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.10.013 · Cited by 35
Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure
Baker, D. W., Bahler, R. C., Finkelhor, R. S., & Lauer, M. S. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00396-x · Cited by 36
Potential Therapeutic Strategies for Hypertension‐Exacerbated Cardiotoxicity of Anticancer Drugs
Kuriakose, R. K., Kukreja, R. C., & Xi, L. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8139861 · Cited by 38
Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial
Sandesara, P. B., O’Neal, W. T., Kelli, H. M., Topel, M. L., Samman‐Tahhan, A., & Sperling, L. S. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007475 · Cited by 37
“Systemic hypertension is the most prevalent modifiable risk factor,(1) and its presence confers an increased risk of developing clinically apparent heart failure.(3,4)”
Background
Heart Failure Due to Systolic Dysfunction and Mortality in Diabetes: Pooled Analysis of 39,505 Subjects
Kamalesh, M., & Cleophas, T. J. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.11.006 · Cited by 36
The burden of cardiovascular disease: following the link from hypertension to myocardial infarction and heart failure
Black, H. R. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00969-5 · Cited by 36
“Hypertension is the most common risk factor for the development of HF, the final stage in the continuum of CVD.(2) Uncontrolled high BP, as well as other closely associated CV risk factors such as obesity, diabetes, smoking, and dyslipidemia, can lead to left ventricular hypertrophy (LVH) and/or MI, progressive diasto…”
BackgroundInfluential
Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: the St. Petersburg study
Конради, А. О., Rudomanov, O. G., Zaharov, D. V., Крутиков, А. Н., Вахрамеева, Н. В., Yakovleva, О. I., Alexeyeva, N. P., & Shlyakhto, E. V. (2004) · Blood Pressure · doi:10.1080/08037050410031855 · Cited by 36
“in men and 110 g/m(2) in women [17], or LVMI more than 125 g/m(2) for both sexes [4], or greater 131/110 in males/ females (Levy criteria) [18], or more than 116/104 g/m 2”
BackgroundResult
Treatment of heart failure in Dutch general practice
Bongers, F., Schellevis, F., Bakx, C., van den Bosch, W. J., & van der Zee, J. (2006) · BMC Family Practice · doi:10.1186/1471-2296-7-40 · Cited by 36
“Hypertension, coronary heart disease, valve diseases and atrial fibrillation are not only important coexisting disorders but they also contribute to the development of HF and play a key role in its progression and response to therapy [19].”
Cardiac Microvasculature in DOCA-Salt Hypertensive Rats
Larouche, I., & Schiffrin, E. L. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.795 · Cited by 36
Review: From Hypertension to Heart Failure — Are There Better Primary Prevention Strategies?
Meredith, P., & Östergren, J. (2006) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2006.012 · Cited by 36
“Hypertension is of course not the sole factor contributing to the development of heart failure but multi-variate analysis using time-dependent modelling revealed that whilst myocardial infarction (MI) conferred the greatest risk of developing heart failure, because of its high prevalence, hypertension carried the grea…”
Result
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy
Cappola, T. P., Cope, L., Cernetich, A., Barouch, L. A., Minhas, K. M., Irizarry, R. A., Parmigiani, G., Durrani, S., Lavoie, T. L., Hoffman, E. P., et al. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00156.2002 · Cited by 36
“LVH is a characteristic pathological feature of common heart diseases such as congestive heart failure and hypertension and is an independent predictor of cardiovascular death (15).”
Background
Pulse pressure index (pulse pressure/systolic pressure) may be better than pulse pressure for assessment of cardiovascular outcomes
Peng-lin, Y., & Li, Y. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.041 · Cited by 35
Chocolate Consumption and Risk of Heart Failure in the Physicians' Health Study
Petrone, A. B., Gaziano, J. M., & Djoussé, L. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.180 · Cited by 35
Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depression
Piepenburg, S. M., Faller, H., Störk, S., Ertl, G., & Angermann, C. E. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1348-6 · Cited by 35
Dietary Approaches to Stop Hypertension Diet Concordance and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis
Campos, C. L., Wood, A. C., Burke, G. L., Bahrami, H., & Bertoni, A. G. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.11.022 · Cited by 38
Early and Quantitative Assessment of Myocardial Deformation in Essential Hypertension Patients by Using Cardiovascular Magnetic Resonance Feature Tracking
Liu, H., Wang, J., Pan, Y., Ge, Y., Guo, Z., & Zhao, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-60537-x · Cited by 35
Sex-related differences in patients' responses to heart failure therapy
Barsheshet, A., brenyo, A. J., Goldenberg, I., & Moss, A. J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.10 · Cited by 35
Eplerenone
Croom, K. F., & Perry, C. M. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505010-00007 · Cited by 35
Sex Differences in the Association of Childhood Socioeconomic Status With Adult Blood Pressure Change
Janicki‐Deverts, D., Cohen, S., Matthews, K. A., & Jacobs, D. R. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31825e32e8 · Cited by 36
“heart failure cases among women compared with 39% of cases among men (15).”
Result
Hypertension and Cardiac Failure in its Various Forms
Gaddam, K. K., Verma, A., Thompson, M., Amin, R. R., & Ventura, H. O. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.005 · Cited by 35
“tablished that antihypertensive treatment results in regression of LVH and reduces the risk of developing heart failure by about 50%.(1,37,38) Antihypertensive treatment with drugs from all classes except direct vasodilators is effective in reversing LVH.”
Left Ventricular Diastolic Dysfunction in Diabetic Patients
Tsujino, T., Kawasaki, D., & Masuyama, T. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606040-00002 · Cited by 34
The Genomic Architecture of Sporadic Heart Failure
Dorn, G. W. (2011) · Circulation Research · doi:10.1161/circresaha.110.229260 · Cited by 36
Congestive Heart Failure in the Elderly: The Cardiovascular Health Study
Mathew, S. T., Gottdiener, J. S., Kitzman, D. W., Aurigemma, G. P., & Gardin, J. M. (2004) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2004.02121.x · Cited by 35
Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibodies to human platelets.
Christie, D. J., Weber, R. W., Mullen, P. C., Cook, J. M., & Aster, R. H. (1984) · PubMed · Cited by 35
Treating Hypertension in Older Adults
Aronow, W. S. (2009) · Drug Safety · doi:10.2165/00002018-200932020-00004 · Cited by 32
Metabolic Syndrome and Heart Failure—The Risk, Paradox, and Treatment
Gaddam, K. K., Ventura, H. O., & Lavie, C. J. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0179-x · Cited by 35
Urinary potassium excretion and risk of cardiovascular events
Kieneker, L. M., Gansevoort, R. T., de Boer, R. A., Brouwers, F. P. J., Feskens, E. J. M., Geleijnse, J. M., Navis, G. J., Bakker, S. J. L., & Joosten, M. M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.106773 · Cited by 34
Epidemiology of comorbidities in patients with hypertension
Shrestha, P. L., Shrestha, P. A., & Vivo, R. P. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000298 · Cited by 35
Cardiovascular outcome in treatment-resistant hypertension
Holmqvist, L. D., Boström, K. B., Kahan, T., Schiöler, L., Hasselström, J., Hjerpe, P., Wettermark, B., & Manhem, K. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001561 · Cited by 34
“Data from the Framingham study suggest that hypertension constitutes the highest attributable risk for heart failure [23].”
Method
Guías de práctica clínica sobre prevención de la enfermedad cardiovascular: Versión resumida
Graham, I. D., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2008) · Revista Española de Cardiología · Cited by 33
The Transition from Hypertension to Hypertensive Heart Disease and Heart Failure: The Prefers Hypertension Study
Ekström, M., Hellman, A., Hasselström, J., Hage, C., Kahan, T., Ugander, M., Wallén, H., Persson, H., & Linde, C. M. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12612 · Cited by 36
Sex Influence on Heart Failure Prognosis
Postigo, A., & Martínez‐Sellés, M. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.616273 · Cited by 35
“Levy and collaborators showed that the adjusted risk for HF development was about 2-fold in hypertensive men but 3-fold in hypertensive women compared to normotensive patients (35).”
Result
Impact of Gestational Hypertension on Left Ventricular Function and Geometric Pattern
Cho, K. I., Kim, S.-M., Shin, M., Kim, E. J., Cho, E.-J., Seo, H., Shin, S., Yoon, S., & Choi, J.-H. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-0763 · Cited by 34
Role of hypertension, diabetes, obesity, and race in the development of symptomatic myocardial dysfunction in a predominantly minority population with normal coronary arteries
Dwyer, E. M., Asif, M., Ippolito, T., & Gillespie, M. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90239-4 · Cited by 34
Hypertensive Therapy: Part II
Franco, V., Oparil, S., & Carretero, O. A. (2004) · Circulation · doi:10.1161/01.cir.0000132615.44103.b1 · Cited by 34
High Incidence of Elevated B‐Type Natriuretic Peptide Levels and Risk Factors for Heart Failure in an Unselected At‐Risk Population (Stage A): Implications for Heart Failure Screening Programs
Silver, M. A., & Pisano, C. (2003) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2003.02589.x · Cited by 34
Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities
Chinali, M., Marco, M. D., D’Addeo, G., Benincasa, M., Romano, C., Galderisi, M., & SIMONE, G. D. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32803fb60c · Cited by 33
Eating frequency is inversely associated with blood pressure and hypertension in Korean adults: analysis of the Third Korean National Health and Nutrition Examination Survey
Kim, S., Park, G.-H., Yang, J. H., Chun, S. H., Yoon, H., & Park, M.-S. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.9 · Cited by 32
Free versus Fixed Combination Antihypertensive Therapy for Essential Arterial Hypertension: A Systematic Review and Meta-Analysis
Mallat, S. G., Tanios, B. Y., Itani, H. S., Lotfi, T., & Akl, E. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161285 · Cited by 35
Prostaglandin E2 EP receptors in cardiovascular disease: An update
Bryson, T. D., & Harding, P. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114858 · Cited by 33
Role of strain echocardiography in patients with hypertension
Oh, J. K., & Park, J. (2022) · Clinical Hypertension · doi:10.1186/s40885-021-00186-y · Cited by 37
Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010
Kovell, L. C., Juraschek, S. P., & Russell, S. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132228 · Cited by 34
“Hypertension is the most common risk factor for HF, shown to have a population attributable risk of 39% in men and 59% in women.[34],[35] Men with hypertension have a higher lifetime risk of developing HF, compared to normotensive men.”
Background
Sex Differences in the Management and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients Presenting to the Emergency Department With Acute Heart Failure.
Zsilinszka, R., Shrader, P., Devore, A., Hardy, N. C., Mentz, R., Pang, P., Peacock, W., Fonarow, G., & Hernandez, A. F. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.12.008 · Cited by 27
Alcohol Consumption and Risk of Heart Failure: A Meta-Analysis
Padilla, H. M., Gaziano, J. M., & Djoussé, L. (2010) · The Physician and Sportsmedicine · doi:10.3810/psm.2010.10.1812 · Cited by 36
Hyperuricemia and the Echocardiographic Measures of Myocardial Dysfunction
Krishnan, E., Hariri, A., Dabbous, O. H., & Pandya, B. J. (2011) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2011.00259.x · Cited by 33
The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase‐2 Up‐Regulation in Renovascular Hypertension
Cáu, S. B. D. A., Guimarães, D. A., Rizzi, É., Ceron, C. S., Gerlach, R. F., & Tanus-Santos, J. E. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12400 · Cited by 33
One-Year Study of Felodipine or Placebo for Stage 1 Isolated Systolic Hypertension
Black, H. R., Elliott, W. J., Weber, M. A., Frishman, W. H., Strom, J. A., Liebson, P. R., Hwang, C., Ruff, D. A., Montoro, R., DeQuattro, V. L., et al. (2001) · Hypertension · doi:10.1161/hy1101.095000 · Cited by 33
Preoperative hypertension: remain wary? ‘Yes’—cancel surgery? ‘No’
Spahn, D. R., & Priebe, H. (2004) · British Journal of Anaesthesia · doi:10.1093/bja/aeh085 · Cited by 33
Evaluating the Use of Angiotensin‐Converting Enzyme Inhibitors For Older Nursing Home Residents with Chronic Heart Failure
Forman, D. E., Cbander, R. B., Lapane, K. L., Shah, P., & Stoukides, J. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb01541.x · Cited by 33
Hipertensión arterial e insuficiencia cardíaca en las consultas de Atención Primaria y de Cardiología en España
Alonso, V. B., Pérez, G. P., González‐Juanatey, J. R., Ezquerra, E. A., Maqueda, I. G., Vidal, J., & Caro, J. L. L. (2003) · Revista Clínica Española · doi:10.1016/s0014-2565(03)71282-x · Cited by 32
Advances in management of heart failure
Heidenreich, P. A., & Sandhu, A. T. (2024) · BMJ · doi:10.1136/bmj-2023-077025 · Cited by 38
The Potentially Modifiable Burden of Incident Heart Failure Due to Obesity: The Atherosclerosis Risk in Communities Study
Loehr, L. R., Rosamond, W. D., Poole, C., McNeill, A. M., Chang, P. P., Deswal, A. M., Folsom, A. R., & HEISS, G. M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq213 · Cited by 31
Status of hypertension screening in the Korea National General Health Screening Program: a questionnaire survey on 210 screening centers in two metropolitan areas
Lee, S. W., Lee, H., Ihm, S., Park, S., Kim, T. H., & Kim, H. C. (2017) · Clinical Hypertension · doi:10.1186/s40885-017-0075-z · Cited by 32
Heart Failure in Diabetes and Related Conditions
Kamalesh, M. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.07.007 · Cited by 32
Regression of ECG-LVH is Associated with Lower Risk of New-Onset Heart Failure and Mortality in Patients with Isolated Systolic Hypertension; The LIFE Study
Larstorp, A. C. K., Okin, P. M., Devereux, R. B., Olsen, M. H., Ibsen, H., Dahlöf, B., Kjeldsen, S. E., & Wachtell, K. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.86 · Cited by 33
Etiología y evaluación diagnóstica en la insuficiencia cardíaca
Segovia, J., Rivera, L. A.-P., Moral, R. P., & Melchor, L. S. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77097-9 · Cited by 35
Salicylate, a Catalytic Inhibitor of Topoisomerase II, Inhibits DNA Cleavage and Is Selective for the α Isoform
Bau, J. T., Kang, Z., Austin, C. A., & Kurz, E. U. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088963 · Cited by 32
Subclinical Cardiac Abnormalities and Kidney Function Decline
Park, M., Shlipak, M. G., Katz, R., Agarwal, S., Ix, J. H., Hsu, C., & Peralta, C. A. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01230212 · Cited by 32
Imaging in hypertensive heart disease
Janardhanan, R., & Kramer, C. M. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.190 · Cited by 32
Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy
Müller-Brunotte, R., Kahan, T., Malmqvist, K. K., & Edner, M. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001622 · Cited by 32
Brain natriuretic peptide as a marker of cardiac involvement in hypertension
Bettencourt, P., Ferreira, A., Sousa, T., Ribeiro, L. V. P. T., Brandão, F., Polónia, J. J., Cerqueira-Gomes, M., & Martins, L. (1999) · International Journal of Cardiology · doi:10.1016/s0167-5273(99)00023-6 · Cited by 32
“failure and is responsible for a wide range of cardiovascular events [3,16,17].”
BackgroundInfluential
Heart failure with preserved ejection fraction in women: the Dutch Queen of Hearts program
den Ruijter, H. M., Pasterkamp, G., Rutten, F. H., Lam, C. S. P., Chi, C., Tan, K. H., van Zonneveld, A. J., Spaanderman, M. E. A., & de Kleijn, D. P. V. (2015) · Netherlands Heart Journal · doi:10.1007/s12471-014-0613-1 · Cited by 31
A combined effect of Cavacurcumin, Eicosapentaenoic acid (Omega-3s), Astaxanthin and Gamma –linoleic acid (Omega-6) (CEAG) in healthy volunteers- a randomized, double-blind, placebo-controlled study
Birudaraju, D., Cherukuri, L., Kinninger, A., Chaganti, B. T., Shaikh, K. A., Hamal, S. A., Flores, F. R., Roy, S. K., & Budoff, M. J. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.09.011 · Cited by 32

Authors: Levy, D.
Affiliations: Framingham Heart Study (US)
Corresponding author: Levy, Daniel
ORCID: Levy, Daniel
Venue: JAMA: The Journal of the American Medical Association
Publisher: American Medical Association (AMA)
Published: 1996-05-22
Volume: 275
Issue: 20
Pages: 1557
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1996.03530440037034
OpenAlex: W2023515446
Cited by: 2,155
References: 46
Citations by year: 2026: 32 · 2025: 62 · 2024: 62 · 2023: 85 · 2022: 82 · 2021: 73 · 2020: 71 · 2019: 86 · 2018: 70 · 2017: 75 · 2016: 68 · 2015: 98 · 2014: 86 · 2013: 102 · 2012: 108
FWCI: 27.57
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc038038-022)
National Heart, Lung, and Blood Institute (N01-HC-38038)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: hypertension, congestive heart failure, population attributable risk, heart failure risk factors, myocardial infarction, diabetes mellitus, left ventricular hypertrophy, valvular heart disease, blood pressure control, Framingham Heart Study, Framingham Offspring Study
MeSH terms: Adult, Aged, Diastole, Female, Heart Failure, Humans, Hypertension, Longitudinal Studies, Male, Middle Aged, Risk Factors, Systole, Cohort Studies, Multivariate Analysis, Proportional Hazards Models, Survival Analysis, Hypertrophy, Left Ventricular, Disease Progression, Ventricular Dysfunction, Left

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Progression From Hypertension to Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks